Newstral
BioMarin Pharmaceutical
- Hundreds of tech and biotech layoffs rattle Bay Area job marketSan Jose Mercury News
- BBiotech Stocks Are Up by Double Digits. It's Still a Bear Market.3 min readbarrons.com
- GFDA Approves First Drug to Treat Genetic Mutation Causing DwarfismGuardian Liberty Voice
- BCancer Concerns Are a New Worry for Gene Therapy. BioMarin Stock Is Falling.2 min readbarrons.com
- Digital Medicine Is (Finally) Here To StayForbes
- BuniQure Stock Is Higher After Investigators Conclude Its Gene Therapy Treatment Was Unlikely to Have Caused a Patient's Cancerbarrons.com
- BBioMarin’s Study of Its Hemophilia Gene-Therapy Looked Goodbarrons.com
- BGene-Therapy Firm Bluebird Bio Is Spinning Off Its Cancer Programsbarrons.com
- After A Healthy Correction Can BioMarin Stock Offer Any Upside?Forbes
- BFDA Delays Start of Sarepta’s Gene Therapy Trialbarrons.com
- BBioMarin Slumps After FDA Rejects Its Hemophilia Gene Therapybarrons.com
- BWhat Sanofi Might Buy With Its Regeneron Windfallbarrons.com
- BBuy Innovative Growth Companies Like BioMarin and L3Harris, Abby Joseph Cohen Saysbarrons.com
- BBioMarin Stock Jumps as Analyst Calls Doubts Over Hemophilia Drug ‘Overblown’barrons.com
- Concord woman who faced deportation and end to life-saving treatment gets a two-year reprieveSan Jose Mercury News
- Why Has Alnylam’s Stock Gained 25% In The Last Two WeeksForbes
- BGene-Therapy Firm Audentes Sells for Double Its Share Price. Analysts Expect More Deals.barrons.com
- BBioMarin Stock Jumps on Analyst Upgradebarrons.com
- BBuy Big Biotech — But Not Gilead, Analyst Saysbarrons.com
- BBioMarin Stock Rises on Earnings Beatbarrons.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.